The FDA has approved two artificial formulations of THC for treating particular circumstances: nabilone and dronabinol. THC activates each CB1 and CB2 receptors. By means of its actions on cannabinoid receptors in the central nervous program THC regulates neurotransmission leading to psychotropic consequences, including regulation of emotions, m